Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
134M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
10.2M
-
Shares change
-
-1.85M
-
Total reported value, excl. options
-
$47.7M
-
Value change
-
-$8.84M
-
Number of buys
-
12
-
Number of sells
-
-15
-
Price
-
$4.67
Significant Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q3 2021
35 filings reported holding CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share as of Q3 2021.
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.2M shares
of 134M outstanding shares and own 7.63% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (3.07M shares), Oasis Management Co Ltd. (2.5M shares), Man Group plc (1.78M shares), BlueCrest Capital Management Ltd (1.45M shares), Quinn Opportunity Partners LLC (324K shares), BARCLAYS PLC (205K shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (195K shares), Qube Research & Technologies Ltd (195K shares), NATIXIS ADVISORS, L.P. (175K shares), and Verition Fund Management LLC (84K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.